Shi Ouyang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Obstetrics and Gynecology top 10%
- COVID-19 Impact on Reproduction
Papers in
-
- Inflammasome and immune disorders 3
- Epidemiology 14
- Liver Disease Diagnosis and Treatment 5
- Hepatitis B Virus Studies 4
- Co-authors
- HengAn Wu (1 shared paper)Weilu Kuang (1 shared paper)Guodong Zhu (7 shared papers)Jiangping Xu (4 shared papers)Dan Xie (3 shared papers)Xu‐Guang Guo (8 shared papers)Yufang Cheng (1 shared paper)Yanjun Zhang (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (2 papers)Journal of Enzyme Inhibition and Medicinal Chemistry (1 paper)Recent Patents on Anti-Cancer Drug Discovery (1 paper)Frontiers in Immunology (1 paper)Analytica Chimica Acta (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Shi Ouyang
35 papers receiving 634 citations
Peers
Comparison fields: 5 of 96
- Cancer Research 169
- Obstetrics and Gynecology 52
- Geriatrics and Gerontology 22
- Hepatology 42
- Infectious Diseases 82
Countries citing papers authored by Shi Ouyang
This map shows the geographic impact of Shi Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi Ouyang more than expected).
Fields of papers citing papers by Shi Ouyang
This network shows the impact of papers produced by Shi Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi Ouyang. The network helps show where Shi Ouyang may publish in the future.
Co-authors
The 25 scholars most cited alongside Shi Ouyang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 129 | |
| 2 | 2021 | 66 | |
| 3 | 2006 | 61 | |
| 4 | 2020 | 56 | |
| 5 | 2018 | 53 | |
| 6 | 2018 | 35 | |
| 7 | 2023 | 26 | |
| 8 | Effects of timosaponins on learning and memory abilities of rats with dementia induced by lateral cerebral ventricular injection of amyloid beta- peptide. | 2005 | 25 |
| 9 | 2015 | 23 | |
| 10 | 2021 | 20 | |
| 11 | 2020 | 17 | |
| 12 | 2020 | 15 | |
| 13 | 2020 | 15 | |
| 14 | 2017 | 14 | |
| 15 | 2024 | 13 | |
| 16 | 2020 | 12 | |
| 17 | 2023 | 10 | |
| 18 | 2012 | 7 | |
| 19 | 2020 | 7 | |
| 20 | 1997 | 7 |
About Shi Ouyang
Shi Ouyang is a scholar working on Molecular Biology, Epidemiology, Hepatology, Infectious Diseases and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 647 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (5 papers), Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (4 papers), Cancer-related molecular mechanisms research (3 papers), Inflammasome and immune disorders (3 papers), Genetic factors in colorectal cancer (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (169 citations), Obstetrics and Gynecology (52 citations), Geriatrics and Gerontology (22 citations), Hepatology (42 citations) and Infectious Diseases (82 citations). Shi Ouyang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include HengAn Wu, Weilu Kuang, Guodong Zhu, Jiangping Xu, Dan Xie, Xu‐Guang Guo, Yufang Cheng, Yanjun Zhang, Han‐Ting Zhang and Shenglan Guo. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Enzyme Inhibition and Medicinal Chemistry, Recent Patents on Anti-Cancer Drug Discovery, Frontiers in Immunology and Analytica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.